Bank of Montreal
MDNA

Bank of Montreal’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Bank of Montreal’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-38,053
Closed -$101K – 3971
2021
Q3 		$101K Sell
38,053
-7,197
-16% -$17.8K ﹤0.01% 3450
2021
Q2 		$144K Buy
45,250
+36,263
+404% +$134K ﹤0.01% 3276
2021
Q1 		$36K Buy
8,987
+1,657
+23% +$6.75K ﹤0.01% 3840
2020
Q4 		$31K Buy
7,330
+4,887
+200% +$19.7K ﹤0.01% 4213
2020
Q3 		$10K Buy
+2,443
New +$9.83K ﹤0.01% 4145

Other funds holding MDNA

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return

Bank of Montreal's MDNA Position: Q4 2021 in Review

Bank of Montreal sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q4 2021, closing a stake of 38,053 shares — an estimated $101K sold.

Bank of Montreal first reported a position in MDNA in Q3 2020 and held it in 5 quarters. The position peaked at $144K in Q2 2021. 23 funds tracked by Wall St. Rank hold MDNA as of Q4 2021.

  • Bank of Montreal reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q4 2021 after selling out during the quarter.
  • Bank of Montreal sold 38,053 Medicenna Therapeutics Corp. Common Shares shares in Q4 2021, an estimated $101K.
  • Bank of Montreal first reported a position in Medicenna Therapeutics Corp. Common Shares in Q3 2020 and held it in 5 quarters.
  • Bank of Montreal's Medicenna Therapeutics Corp. Common Shares position peaked at $144K in Q2 2021.
  • 23 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.